Paper36712142
Steroid-Refractory Autoimmune Myocarditis after Pembrolizumab Therapy: Failure of Equine Anti-Thymocyte Globulin to Prevent Heart Failure.
Baclig NV and 7 others. J Clin Case Rep, 2019. Cited by 7 papers, by iCite.
Cite this record
ConductScience Library. Steroid-Refractory Autoimmune Myocarditis after Pembrolizumab Therapy: Failure of Equine Anti-Thymocyte Globulin to Prevent Heart Failure. Papers, record 36712142. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36712142
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Steroid-Refractory Autoimmune Myocarditis after Pembrolizumab Therapy: Failure of Equine Anti-Thymocyte Globulin to Prevent Heart Failure.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| VA999999 | Intramural VA | United States | PubMed |
Source PubMed
References19
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 29567210 | Myocarditis in Patients Treated With Immune Checkpoint Inhibitors. | J Am Coll Cardiol | 2018 | https://conductscience.org/library/papers/29567210 | PubMed |
| 2 | 30191849 | Immune checkpoint inhibitors and cardiovascular toxicity. | Lancet Oncol | 2018 | https://conductscience.org/library/papers/30191849 | PubMed |
| 3 | 27141885 | Safety profiles of anti-CTLA-4 and anti-PD-1 antibodies alone and in combination. | Nat Rev Clin Oncol | 2016 | https://conductscience.org/library/papers/27141885 | PubMed |
| 4 | 28833116 | Fatal Myocarditis Following Treatment with the PD-1 Inhibitor Nivolumab. | J Forensic Sci | 2018 | https://conductscience.org/library/papers/28833116 | PubMed |
| 5 | 28797029 | Successful use of equine anti-thymocyte globulin (ATGAM) for fulminant myocarditis secondary to nivolumab therapy. | Br J Cancer | 2017 | https://conductscience.org/library/papers/28797029 | PubMed |
| 6 | 26981243 | Systemic inflammation in a melanoma patient treated with immune checkpoint inhibitors-an autopsy study. | J Immunother Cancer | 2016 | https://conductscience.org/library/papers/26981243 | PubMed |
| 7 | 28220466 | Cardiovascular Toxicities Associated with Cancer Immunotherapies. | Curr Cardiol Rep | 2017 | https://conductscience.org/library/papers/28220466 | PubMed |
| 8 | 27532025 | Cardiotoxicity associated with CTLA4 and PD1 blocking immunotherapy. | J Immunother Cancer | 2016 | https://conductscience.org/library/papers/27532025 | PubMed |
| 9 | 25901283 | Acute heart failure due to autoimmune myocarditis under pembrolizumab treatment for metastatic melanoma. | J Immunother Cancer | 2015 | https://conductscience.org/library/papers/25901283 | PubMed |
| 10 | 29802220 | Myocarditis Associated with Immune Checkpoint Inhibitors: An Expert Consensus on Data Gaps and a Call to Action. | Oncologist | 2018 | https://conductscience.org/library/papers/29802220 | PubMed |
| 11 | 29104763 | Cardiotoxicity of immune checkpoint inhibitors. | ESMO Open | 2017 | https://conductscience.org/library/papers/29104763 | PubMed |
| 12 | 29802219 | Immune Checkpoint Inhibitor-Associated Myocarditis. | Oncologist | 2018 | https://conductscience.org/library/papers/29802219 | PubMed |
| 13 | 27806233 | Fulminant Myocarditis with Combination Immune Checkpoint Blockade. | N Engl J Med | 2016 | https://conductscience.org/library/papers/27806233 | PubMed |
| 15 | 27084345 | Neurological, respiratory, musculoskeletal, cardiac and ocular side-effects of anti-PD-1 therapy. | Eur J Cancer | 2016 | https://conductscience.org/library/papers/27084345 | PubMed |
| 16 | 29567824 | Serial Troponin for Early Detection of Nivolumab Cardiotoxicity in Advanced Non-Small Cell Lung Cancer Patients. | Oncologist | 2018 | https://conductscience.org/library/papers/29567824 | PubMed |
| 17 | 22614989 | Management of immune-related adverse events and kinetics of response with ipilimumab. | J Clin Oncol | 2012 | https://conductscience.org/library/papers/22614989 | PubMed |
| 18 | 29965858 | Autoimmune Myocarditis Caused by Immune Checkpoint Inhibitors Treated With Antithymocyte Globulin. | J Immunother | 2018 | https://conductscience.org/library/papers/29965858 | PubMed |
| 19 | 29126352 | Fatal myocarditis and rhabdomyolysis induced by nivolumab during the treatment of type B3 thymoma. | Clin Toxicol (Phila) | 2018 | https://conductscience.org/library/papers/29126352 | PubMed |
| 20 | 29077601 | Life-threatening Autoimmune Cardiomyopathy Reproducibly Induced in a Patient by Checkpoint Inhibitor Therapy. | J Immunother | 2018 | https://conductscience.org/library/papers/29077601 | PubMed |
Cited by5
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 7 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42148146 | Case Report: Long-term survival in advanced PD-L1-high squamous cell lung cancer following severe immune-related cardiotoxicity. | Front Immunol | 2026 | https://conductscience.org/library/papers/42148146 | PubMed |
| 40178703 | Updates in Diagnosis and Treatment of Immune Checkpoint Inhibitor Myocarditis. | Curr Cardiol Rep | 2025 | https://conductscience.org/library/papers/40178703 | PubMed |
| 39263485 | Therapeutic agents for steroid-refractory immune checkpoint inhibitor-related myocarditis: a narrative review. | Cardiovasc Diagn Ther | 2024 | https://conductscience.org/library/papers/39263485 | PubMed |
| 39256296 | Steroid-Refractory Myocarditis Induced by Immune Checkpoint Inhibitor Responded to Infliximab: Report of Two Cases and Literature Review. | Cardiovasc Toxicol | 2024 | https://conductscience.org/library/papers/39256296 | PubMed |
| 38233099 | Corticosteroid-resistant immune-related adverse events: a systematic review. | J Immunother Cancer | 2024 | https://conductscience.org/library/papers/38233099 | PubMed |
Genes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| CTLA4 | 1493 | PubTator's text mining | https://conductscience.org/library/genes/1493 | NCBI Gene |
| PDCD1 | 5133 | PubTator's text mining | https://conductscience.org/library/genes/5133 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/36712142
GET https://conductscience.org/api/papers/v1/36712142/authors